Recruiting Thrombocytopenia Studies in Denver
About Thrombocytopenia Clinical Trials in Denver
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 1 thrombocytopenia clinical trials recruiting participants in Denver, COLORADO. These studies are seeking a combined 171 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Denver — FAQ
Are there thrombocytopenia clinical trials in Denver?
Yes, there are 1 thrombocytopenia clinical trials currently recruiting in Denver, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 1 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated March 2, 2026 from ClinicalTrials.gov